EIN 42-1757010

California Oncology Research Institute

IRS 501(c) type
501(c)(3)
Num. employees
0
Year formed
2008
Most recent tax filings
2023-12-01
NTEE code, primary
Description
California Oncology Research Institute fosters innovative research and treatments, educates communities, ensures access to early detection screenings, and conducts outreach activities to underserved populations related to cancer screening and prevention. The institute funds educational events, free cancer screenings, psychosocial support, cancer prevention training, and outreach activities for youth organizations.
Total revenues
$1,742,110
2023
Total expenses
$355,115
2023
Total assets
$3,207,777
2023
Num. employees
0
2023

Program areas at California Oncology Research Institute

CALIFORNIA ONCOLOGY RESEARCH INSTITUTE (CORI) FUNDED EDUCATIONAL EVENTS AND FREE CANCER SCREENINGS IN THE INNER CITY. THESE EVENTS HAVE BEEN EXPANDED TO INCLUDE PSYCHOSOCIAL SUPPORT AND CANCER PREVENTION TRAINING. THE OUTREACH ACTIVITIES HAVE ALSO BEEN EXPANDED TO INCLUDE YOUTH ORGANIZATIONS SUCH AS THE DREAM CENTER (AN INTERNATIONAL ORGANIZATION DEVOTED TO HELPING YOUNG INDIVIDUALS AND COMMUNITIES IN NEED). CORI DOCTORS WHO VOLUNTEER THEIR TIME HAVE EITHER EDUCATED OR PROVIDED FREE CANCER SCREENINGS TO MORE THAN 300,000 PEOPLE THROUGHOUT THE GREATER LOS ANGELES AREA. AS A RESULT, CORI WAS RECOGNIZED BY THE CITY OF LOS ANGELES FOR THIS WORK.DURING THE 2023 YEAR CORI CO-SPONSORED THREE EDUCATIONAL OUTREACH AND CANCER SCREENING EVENTS WITH COMMUNITY PARTNER FIGHTING AGAINST CANCER FOR EVERYONE IN THE SPIRIT (FACES). SATURDAY JUNE 3, 2023 CORI AND FACES HELD AN ANNUAL PROSTATE CANCER AWARENESS AND SHINGLES EVENT CENTERED ON "KNOWLEDGE IS POWER". THIS EVENT WAS OPEN TO THE COMMUNITY AND HOSTED AT INGLEWOOD SOUTHSIDE CHRISTIAN CHURCH. MULTITALENTED ACTOR/PRODUCER AND PROSTATE CANCER SURVIVOR ALONZO "LONZO" WILLIAMS SERVED AS THE EVENT MASTER OF CEREMONY. DR. ANTON BILCHIK GAVE AN OVERVIEW OF CORI AND SHARED WITH THE AUDIENCE THE IMPORTANCE OF REGULAR CANCER SCREENINGS AND HOW THESE TESTS HELP TO DETECT CANCER EARLY AND SAVE LIVES. DR. JENNIFER LINEHAN WAS THE SPECIAL GUEST SPEAKER AND DELIVERED A PRESENTATION ON PROSTATE CANCER. ESTABAN ESPINOZA WITH THE LA COUNTY DEPARTMENT OF PUBLIC HEALTH GAVE A BRIEF PRESENTATION ON SHINGLES. FREDDIE MUSE JR - FOUNDER AND PRESIDENT OF THE MEN'S CANCER NETWORK INC., A TWO TIME PROSTATE CANCER SURVIVOR, GAVE A TESTIMONIAL AND AN OVERVIEW OF THE CANCER WELLNESS HUB SURVEY AND AN INFOGRAPHIC SHEET THAT SHOWED THE VARIOUS CANCER SIGNS, AND SYMPTOMS AND THE SCREENINGS ASSOCIATED WITH EACH. THE EVENT WAS A GREAT SUSCESS WITH OVER 80 PEOPLE ATTENDING. DR. LINEHAN'S PRESENTATION WAS FILMED AND CAN BE VIEWED ONLINE ON THE CORI WEBSITE.ON AUGUST 19, 2023 CORI CO-SPONSORED AN ALOPECIA AND PSORIASIS AWARENESS EVENT HELD AT THE INGLEWOOD SOUTHSIDE CHRISTIAN CHURCH. PEYTON HEMANN GAVE A PRESENTATION ON ALOPECIA AND LESHA TICKNOR AND LEANDRA DOAN GAVE A PRESENTATION ON PSORIASIS. ANGELA STEWART GAVE A TESTIMONIAL ABOUT HER HAIR LOSS JOURNEY AND BATTLING ALOPECIA. MASTER STYLIST PATRICE DANIELS GAVE A VERY INFORMATIVE PRESENTATION ON PROTECTIVE HAIR STYLES, PROPER HAIR CARE AND HOW TO RESTORE DAMAGED HAIR AND HAIR LOSS. THIS EVENT WAS ATTENDED BY MORE THAN 100 WOMEN.ON OCTOBER 7, 2023 CORI AND FACES HELD A BREAST CANCER AWARENESS AND HEALTH SCREENING EVENT AT INGLEWOOD SOUTHSIDE CHRISTIAN CHURCH. THIS YEAR'S THEME WAS CENTERED ON EMPOWERING FAMILY HEALTH. DR. LA SHAWN DENISE WITT WAS THE MISTRESS OF CEREMONY. DR. CRYSTAL FRANCHER, BREAST SURGICAL ONCOLOGIST, WAS THE SPECIAL GUEST SPEAKER. SHE GAVE A PRESENTATION ENTITLED, "BREAST CANCER AWARENESS: FROM BASICS TO BEYOND THE PINK RIBBONS". HER PRESENTATION TOUCHED ON PREVENTION, EARLY DETECTION, SCREENING, SYMPTOMS ETC. DR. ANTON BILCHIK GAVE AN OVERVIEW OF CORI AND THE IMPORTANCE OF CANCER SCREENINGS. LA COUNTY DEPARTMENT OF PUBLIC HEALTH EDUCATORS ASENIQ SHAHID-WILLIAMS AND VICTORIA JONES GAVE A PRESENTATION ON SHINGLES AND HOW TO PREVENT THE DISEASE. CANCER SURVIVORS LORETTA RANDALL, DANA HOLMES AND DENISE WASHINGTON GAVE TESTIMONIALS ABOUT THEIR CANCER JOURNEYS AND THE LIFESTYLE CHANGES THEY HAVE ADOPTED. FREE BLOOD PRESSURE SCREENINGS WERE PROVIDED BY AN AFRICAN AMERICAN NURSING SORORITY GROUP. THIS GREAT EVENT HAD 125 MEN AND WOMEN IN ATTENDANCE. THE VIDEO OF THIS EVENT IS BEING POSTED TO THE CORI WEBSITE AS WELL AS YOUTUBE.IN ADDITION TO COMMUNITY EVENTS CORI IS CONDUCTING RESEARCH:At over 50,000 deaths per year, colorectal cancer (CRC) is the second most common cause of cancer deaths in the US and disproportionately impacts medically underserved racial/ethnic minority communities. Colorectal cancer incidence and deaths are highest in Black Americans, followed closely by American Indians/Alaska Natives and lowest in Asians/Pacific Islanders. Furthermore, people with the lowest socioeconomic status are 40% more likely to be diagnosed with colorectal cancer than those with the highest socioeconomic status. New colorectal cancer screening recommendations lower the age from 50 to 45 for individuals at average risk for colorectal cancer. Raising awareness for colorectal cancer and screening options in underserved communities remains critical. To do so will require sustained and innovative efforts from health care providers and researchers, creating networks of key opinion leaders in the local communities while making screening and prevention services affordable, easy to obtain, and widespread. Screening for colorectal cancer (CRC) reduces the chances of dying from CRC, reducing both incidence and mortality of the disease by detecting precancerous and cancerous lesions. In total, about 50% of the decline in CRC between 1975 and 2000 is attributed to screening. But low income and racial/ethnic minority individuals have not been offered screening in effective numbers, resulting in higher death rates in these groups. Mysteriously, in the last 5 years there has been a 4-5 fold increase in the number of early-onset CRC cases in young people (under 50 years of age) and the reason for this is still unknown. This is a serious health crisis as the younger generation is being affected with no known cause. All these national patterns hold true in California, and more specifically, the Los Angeles area. Only 61.5% of Californians have received a colonoscopy in the past 10 years, and only 22% have received a blood or stool test in the last year. In Los Angeles, 64.1% of community members had a CRC screening.Access to effective screening and early treatment programs are the best hope to serve all patients with CRC. Compounding existing inequities, patients at risk for the worst CRC outcomes are less likely to participate in research focused on improving early detection methods and precision prevention (i.e., development of new biological and genetic markers for CRC and its precursors in blood and stool samples). CRC screening rates are the worst in populations of people with lower levels of higher education and income. These individuals also do not have health insurance and lack access to adequate healthcare facilities and are typically from racial/ethnicity minority backgrounds. In addition to increasing screening rates among younger people of color, it is also important to conduct research to understand the cause of the disproportionate increase in CRC, especially among younger Black Americans. The study of tissue using a multi-omics platform can help us better understand the causes of the increase in CRC in this community and potentially identify targets for treatment.Accordingly, California Oncology Research Institute (CORI) in collaboration with Providence Saint Johns Cancer Institute, and Providence Health Research Accelerator (HRA) are conducting research to pinpoint and address unique local needs of minority and medically underserved communities and turn participating at-risk communities into "zones" with high rates of colorectal cancer screening. The research provides colorectal cancer testing and study samples collected via approved tests for colorectal cancer, including colonoscopy, CT colonography, flexible sigmoidoscopy, and at-home stool tests that analyze fecal DNA and/or blood. In doing so the research will provide significantly enhanced opportunities for residents to participate in CRC screenings, while research will develop better approaches to colorectal cancer interception for racial and ethnic minority patients generally.

Who funds California Oncology Research Institute

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Jewish Community Foundation of the Jewish Federation Council of Greater LaGeneral Support$60,000
Vanguard Charitable Endowment ProgramFor Recipient's Exempt Purpose$10,000
Boudjakdji FoundationResearch$4,000

Personnel at California Oncology Research Institute

NameTitleCompensation
Anton J. BilchikBoard Member$0
Jonathan JacobsPresident$0
Ruth WeilDirector / Treasurer$0
Anton Bilchik MedicalDirector

Financials for California Oncology Research Institute

RevenuesFYE 12/2023
Total grants, contributions, etc.$1,595,683
Program services$0
Investment income and dividends$50,995
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$95,432
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$1,742,110

Form 990s for California Oncology Research Institute

Fiscal year endingDate received by IRSFormPDF link
2023-122024-11-14990View PDF
2022-122023-11-13990View PDF
2021-122022-11-14990View PDF
2020-122021-11-15990View PDF
2019-122021-01-28990View PDF
...and 9 more Form 990s
Data update history
February 7, 2025
Posted financials
Added Form 990 for fiscal year 2023
May 18, 2024
Received grants
Identified 1 new grant, including a grant for $4,000 from Boudjakdji Foundation
January 22, 2024
Posted financials
Added Form 990 for fiscal year 2022
January 1, 2024
Received grants
Identified 1 new grant, including a grant for $60,000 from Jewish Community Foundation of the Jewish Federation Council of Greater La
October 5, 2023
Updated personnel
Identified 4 new personnel
Nonprofit Types
Medical research organizationsResearch centersCharities
Issues
Science and technologyHealthDiseases and disordersMedical disciplines
Characteristics
Conducts researchState / local levelTax deductible donationsNo full-time employeesAccepts online donations
General information
Address
2632 Wilshire Blvd Box 383
Santa Monica, CA 90403
Metro area
Los Angeles-Long Beach-Anaheim, CA
County
Los Angeles County, CA
Website URL
corigroup.org/ 
Phone
(310) 883-0096
IRS details
EIN
42-1757010
Fiscal year end
December
Taxreturn type
Form 990
Year formed
2008
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
H30: Cancer Research
NAICS code, primary
5417: Scientific Research and Development Services
Parent/child status
Independent
California AB-488 details
AB 488 status
May Operate or Solicit for Charitable Purposes
Charity Registration status
Current
FTB status revoked
Not revoked
AG Registration Number
CT0173647
FTB Entity ID
3087639
AB 488 data last updated ("as-of") date
2025-02-05
Free account sign-up

Want updates when California Oncology Research Institute has new information, or want to find more organizations like California Oncology Research Institute?

Create free Cause IQ account